| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6113529 | Critical Reviews in Oncology/Hematology | 2016 | 14 Pages |
Abstract
HRQoL instruments that can better assess and incorporate all the domains affected by CACS are required. Rigorous assessment of costs and benefits of treatment are needed to understand the magnitude of the impact of CACS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Rosanna Tarricone, Giada Ricca, Barbara Nyanzi-Wakholi, Antonieta Medina-Lara,